Impact of in-patient research participation on subsequent heroin use patterns: Implications for ethics and public health

Addiction

Volumn 107, Issue 3, 2012, Pages 642-649

  Roux, Perrine ^a,b   Tindall, Claudia ^a   Fugon, Lionel ^b   Murray, Janet ^a   Vosburg, Suzanne K ^a   Saccone, Phillip ^a   Sullivan, Maria A ^a   Manubay, Jeanne M ^a   Cooper, Ziva D ^a   Jones, Jermaine D ^a   Foltin, Richard W ^a   Comer, Sandra D ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b INSERM   (France)

Author keywords

Abstinence; Access to care; Drug use; Experimental study; Heroin; Opioid maintenance treatment; Self administration; Study completion

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CLINICAL TRIAL (TOPIC); ETHICS; FEMALE; HEROIN DEPENDENCE; HUMAN; HUMAN EXPERIMENT; MALE; PATIENT ATTITUDE; RESEARCH ETHICS; SELF REPORT; TREATMENT OUTCOME;

ADULT; ANALGESICS, OPIOID; CLINICAL TRIALS AS TOPIC; ETHICS, RESEARCH; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; SELF REPORT; THERAPEUTIC HUMAN EXPERIMENTATION; TREATMENT OUTCOME;

EID: 84856726726     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03664.x     Document Type: Article

References (30)

1. Cameron D. C. Drug dependence: some research issues. Bull World Health Organ 1970; 43: 589-98.
2. Haney M., Spealman R. Controversies in translational research: drug self-administration. Psychopharmacology 2008; 199: 403-19.
3. Miller P. G., Strang J., Miller P. M. Addiction Research Methods. Hoboken, NJ: John Wiley and Sons; 2010.
4. Resnik D. B., Koski G. A national registry for healthy volunteers in phase 1 clinical trials. JAMA 2011; 305: 1236-7.
5. Bigelow G. E., Brooner R. K., Walsh S. L., Preston K. L., Liebson I. A. Community outcomes following research exposure to cocaine or opioids. In: IHL, editor. Problems of Drug Dependence 1994: Proceedings of the 56th Annual Scientific Meeting. Washington DC: NIH; 1995, p. 354.
6. Fischman M. W., Schuster C. R., Resnekov L., Shick J. F., Krasnegor N. A., Fennell W. etal. Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psychiatry 1976; 33: 983-9.
7. Elman I., Krause S., Karlsgodt K., Schoenfeld D. A., Gollub R. L., Breiter H. C. etal. Clinical outcomes following cocaine infusion in nontreatment-seeking individuals with cocaine dependence. Biol Psychiatry 2001; 49: 553-5.
8. Pratt W. M., Davidson D. Does participation in an alcohol administration study increase risk for excessive drinking? Alcohol 2005; 37: 135-41.
9. Kirulis K., Zacny J. P. Participation of nondrug abusers in opioid studies and subsequent reported drug use. In: Louis S., Harris P., editors. 60th Annual Scientific Meeting, The College on Problems of Drug Dependence. Scottsdale, AZ: NIH; 1998, p. 309.
10. Vadhan N. P., Hart C. L., Roe B., Colley J., Haney M., Foltin R. W. Substance use and psychosocial outcomes following participation in residential laboratory studies of marijuana, methamphetamine and zolpidem. Am J Drug Alcohol Abuse 2006; 32: 589-97.
11. Comer S. D., Ashworth J. B., Sullivan M. A., Vosburg S. K., Saccone P. A., Foltin R. W. Relationship between rate of infusion and reinforcing strength of oxycodone in humans. J Opioid Manag 2009; 5: 203-12.
12. Comer S. D., Sullivan M. A., Vosburg S. K., Manubay J., Amass L., Cooper Z. D. etal. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers. Addiction 2010; 105: 709-18.
13. Domestic Strategic Intelligence Unit, Drug Enforcement Administration. 2006 Heroin Domestic Monitor Program. Report no.: DEA-07016. Springfield: US Department of Justice-Drug Enforcement Administration; 2007.
14. OASAS. Addiction FYI Yearbook 2009/2010-Part 2. Albany: New York State Office of Alcoholism and Substance Abuse Services (OASAS), Addiction Services for Prevention, Treatment, Recovery; 2010.
15. Comer S. D., Sullivan M. A., Whittington R. A., Vosburg S. K., Kowalczyk W. J. Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology 2008; 33: 1179-91.
16. Velasquez M. M., Carbonari J. P., DiClemente C. C. Psychiatric severity and behavior change in alcoholism: the relation of the transtheoretical model variables to psychiatric distress in dually diagnosed patients. Addict Behav 1999; 24: 481-96.
17. Pantalon M. V., Nich C., Frankforter T., Carroll K. M. The URICA as a measure of motivation to change among treatment-seeking individuals with concurrent alcohol and cocaine problems. Psychol Addict Behav 2002; 16: 299-307.
18. Joe G. W., Simpson D. D., Broome K. M. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998; 93: 1177-90.
19. Nosyk B., Geller J., Guh D. P., Oviedo-Joekes E., Brissette S., Marsh D. C. etal. The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study. Drug Alcohol Depend 2010; 111: 161-5.
20. Bernstein E., Bernstein J., Tassiopoulos K., Valentine A., Heeren T., Levenson S. etal. Racial and ethnic diversity among a heroin and cocaine using population: treatment system utilization. J Addict Dis 2005; 24: 43-63.
21. Bourgois P., Martinez A., Kral A., Edlin B. R., Schonberg J., Ciccarone D. Reinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approach. PLoS Med 2006; 3: e452.
22. Neale J., Sheard L., Tompkins C. N. Factors that help injecting drug users to access and benefit from services: a qualitative study. Subst Abuse Treat Prev Policy 2007; 2: 31-43.
23. DeBeck K., Kerr T., Bird L., Zhang R., Marsh D., Tyndall M. etal. Injection drug use cessation and use of North America's first medically supervised safer injecting facility. Drug Alcohol Depend 2011; 113: 172-6.
24. Wood E., Tyndall M. W., Zhang R., Montaner J. S., Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction 2007; 102: 916-9.
25. Kimber J., Mattick R. P., Kaldor J., van Beek I., Gilmour S., Rance J. A. Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Drug Alcohol Rev 2008; 27: 1-11.
26. Rosen D., Hunsaker A., Albert S. M., Cornelius J. R., Reynolds C. F. 3rd. Characteristics and consequences of heroin use among older adults in the United States: a review of the literature, treatment implications, and recommendations for further research. Addict Behav 2011; 36: 279-85.
27. Li L., Ding Y., Lai W., Lin C., Luo W. Motivational profiles of clients seeking methadone maintenance therapy in China. Drug Alcohol Depend 2011; 118: 335-40.
28. Mowbray O., Perron B. E., Bohnert A. S., Krentzman A. R., Vaughn M. G. Service use and barriers to care among heroin users: results from a national survey. Am J Drug Alcohol Abuse 2010; 36: 305-10.
29. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend 1998; 51: 253-63, discussion 267-258.
30. Messiah A., Loundou A. D., Maslin V., Lacarelle B., Moatti J. P. Physician recognition of active drug use in HIV-infected patients is lower than validity of patient's self-reported drug use. J Pain Symptom Manage 2001; 21: 103-12.